bulk drugs
Healthcare
Steadview Capital makes partial exit from bulk drugs firm
Alternative investment firm Steadview Capital has made back-to-back partial exits from portfolio companies taking advantage of the buoyant stock market ......
Healthcare
Bulk drugs maker to pop out ‘benchmark returns' pill for Morgan Stanley
ZCL Chemicals Ltd is all set to serve up benchmark returns for Morgan Stanley PE Asia as the investor gets ......
Healthcare
Bulk drugs hot up as US state pension fund piles into Steadview-backed API maker
A US state pension fund has invested in a Hyderabad-based active pharmaceutical ingredients (API) maker. This is the latest in a ......
Healthcare
Carlyle weighs possible bid for south India bulk-drugs firm
Private equity firm The Carlyle Group is evaluating a Hyderabad-based bulk-drugs maker as part of its plan to build an ......
Healthcare
Why Indian bulk-drug makers are attracting greater investor interest
Private equity investors as well as pharmaceutical companies are showing higher interest in the bulk-drugs segment in India, industry executives ......
Healthcare
Exclusive: Sole bidder emerges for bankrupt pharma firm Parabolic Drugs
Parabolic Drugs Ltd, a listed bulk drugs manufacturer which is currently undergoing insolvency proceedings, has received a takeover offer from ......
Healthcare
ChrysCap emerges as front runner to invest in Mumbai bulk-drugs maker
Homegrown private equity firm ChrysCapital has emerged as the primary suitor to clinch an investment in a Mumbai-based drugmaker, two ......
Healthcare
Mid-market PE consortium in talks to buy Actis' stake in Symbiotec
Actis Advisers Pvt. Ltd is in the final stages of negotiations with a consortium of fellow private equity firms to ......
Healthcare
Symbiotec Pharmalab gets interest from new set of PE firms
Symbiotec Pharmalab Pvt. Ltd has attracted interest from a new set of global private equity investors, as majority owner Actis ......
